Home › NDC Lookup › Ingredients › Sennosides, Docusate Sodium › 00904-7440-61
Sennosides, Docusate Sodium 50 mg; 8.6 mg Tablet, Film Coated — NDC 00904-7440-61 package photo

Sennosides, Docusate Sodium 50 mg; 8.6 mg Tablet, Film Coated

by Major Pharmaceuticals · 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-7440-61) / 10 TABLET, FILM COATED in 1 BLISTER PACK
NDC 00904-7440-61
🏷️ FDA NDC (as labeled) 0904-7440-61 billing pads the labeler segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 0904-7440-61
Product NDC 0904-7440
11-digit billing NDC 00904744061
NCPDP billing unit EA — each (per item)
RxCUI 998740
UNII F05Q2T2JA0, 3FYP5M0IJX
UPC 0309047440610
Application # M007
SPL Set ID 1768b470-2808-fa46-e063-6394a90ac8d9
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-05-01
Route ORAL
Dosage form TABLET, FILM COATED
Substance DOCUSATE SODIUM; SENNOSIDES
GPI-14 46991002770320
GCN Seq No 048044
GCN 13483
HICL code 021772
Ingredient (HICL) Sennosides/Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNOSIDES-DOCUSATE SODIUM TAB
FDB brand name Sennosides-Docusate Sodium
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0904-7440-61 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-7440-61. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedMay 2024
Product typeHuman Otc Drug
Portfolio629 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name SENNOSIDES-DOCUSATE SODIUM TAB Ingredient Sennosides/Docusate Sodium
📖 About the active ingredient: Docusate Sodium; Sennosides MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
🧪 What is this product?

This is an over-the-counter oral tablet containing two active ingredients commonly used together for digestive relief. Sennosides are a natural plant compound typically used as a laxative to promote bowel movements, while docusate sodium functions as a stool softener to help ease passage. This combination product is marketed under the FDA's over-the-counter monograph rules as a digestive aid. The tablet has a film coating to help protect the active ingredients during swallowing.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color red
ShapeRound
Imprint49;0
Size1 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII O7TSZ97GEP
    A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
  • UNII J9EQA3S2JM
    FD&C Blue No. 1 Aluminum Lake is a blue colorant made by combining FD&C Blue No. 1 dye with aluminum salts. It is used to color tablets, capsules, and other medicines for easy identification and appearance.
  • UNII 6T47AS764T
    Red 40 Lake is a synthetic colorant made by combining Red 40 dye with aluminum hydroxide. It's used to give tablets, capsules, and other medicines a red or pink color for identification and appearance.
  • UNII GYP6Z2JR6Q
    FD&C Yellow No. 6 Aluminum Lake is a yellow colorant made by combining FD&C Yellow No. 6 dye with aluminum salts. It's used to color tablets, capsules, and other medicines so they're easier to identify.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII N6K5787QVP
    Light mineral oil is a clear, odorless liquid derived from petroleum. In medicines, it acts as a lubricant and emollient to help the product spread smoothly and improve texture.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

17 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn starch, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C blue #1 lake, FD&C red #40 lake, FD&C yellow #6 lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, sodium benzoate, sodium lauryl sulfate, stearic acid, talc, titanium dioxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.030 $3.03 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.1651 $16.51 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Feb 2026 May 2026 Aug 2026 $0.033 $0.030
▼ Down 7% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senexon-S 8.6 mg/1; 50 mg 00536-1247-01 RUGBY 100 tablets $0.030 — Availability likely —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 00536-1248-01 RUGBY 100 tablets $0.030 — Availability likely —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mgthis 00904-7440-61 Major 10 tablets $0.030 — Availability likely —
Senna Plus 50 mg/1; 8.6 mg 46122-0625-72 AmerisourceBergen 60 tablets $0.030 — Availability likely —
Stool Softener Laxative 50 mg/1; 8.6 mg 46122-0669-78 AmerisourceBergen 100 tablets $0.030 — Availability likely —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 60687-0622-01 American 100 tablets $0.030 — Availability likely —
Senna Plus 8.6 mg/1; 50 mg 70000-0520-01 CARDINAL 30 tablets $0.030 — Availability likely —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 70000-0526-01 CARDINAL 100 tablets $0.030 — Availability likely —
Senna-S 8.6 mg/1; 50 mg 70677-1069-01 STRATEGIC 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 70677-1094-01 Strategic 100 tablets $0.030 — Availability likely —
Senna S 50 mg/1; 8.6 mg 83324-0135-60 QUALITY 60 tablets $0.030 — Availability likely —
Stool Softener 50 mg/1; 8.6 mg 83324-0136-01 QUALITY 100 tablets $0.030 — Availability likely —
Senna-S 50 mg/1; 8.6 mg 70677-1246-01 Strategic 100 tablets $0.032 — FDA listed +5%
Colace 50 mg/1; 8.6 mg 67618-0110-10 Atlantis 5 tablets $0.414 — Availability likely +1267%
Senokot-S 8.6 mg/1; 50 mg 67618-0310-01 Atlantis 10 tablets $0.414 — Availability likely +1267%
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 00363-0827-20 Walgreens 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 00363-0883-12 Walgreens 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8550-20 Walgreens 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8780-20 Walgreens 200 tablets — — Discontinued —
Senexon-S 8.6 mg/1; 50 mg 00615-8331-39 NCS 30 tablets — — FDA listed —
Senna-S Laxative With Stool Softener 50 mg/1; 8.6 mg 00761-0910-02 Basic 100 tablets — — FDA listed —
Senna S 8.6 mg/1; 50 mg 10135-0669-01 Marlex 100 tablets — — FDA listed —
Stool Softening Senna Laxative 50 mg/1; 8.6 mg 11673-0192-03 TARGET 30 tablets — — FDA listed —
Stool Softener And Stimulant Laxative 8.6 mg/1; 50 mg 11673-0209-01 TARGET 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 16103-0378-07 Pharbest 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 17856-1248-01 ATLANTIC 1 tablet — — FDA listed —
Natural Vegetable Laxative and Stool Softener 50 mg/1; 8.6 mg 21130-0219-03 BETTER 30 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0829-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 21130-0855-20 Safeway, 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0878-20 Safeway, 200 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 21130-0883-30 Safeway, 30 tablets — — FDA listed —
Stool Softener 8.6 mg/1; 50 mg 21130-0902-20 BETTER 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 36800-0084-01 TOP 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 36800-0783-12 TOP 120 tablets — — FDA listed —
Laxative Docusate Sodium with Senna 50 mg/1; 8.6 mg 36800-0861-01 TOPCO 100 tablets — — FDA listed —
Vegetable Laxative and Stool Softner 50 mg/1; 8.6 mg 36800-0938-60 TOPCO 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0355-12 H 120 tablets — — FDA listed —
Stool Softener and Stimulant Laxative 50 mg/1; 8.6 mg 37808-0549-29 H-E-B 240 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0878-12 H 120 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 41163-0755-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant 50 mg/1; 8.6 mg 41163-0778-10 United 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 41163-0829-10 United 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 41163-0883-30 United 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 41226-0192-06 KROGER 60 tablets — — FDA listed —
Stool Softener-Stimulant Laxative 8.6 mg/1; 50 mg 41226-0209-06 Kroger 60 tablets — — FDA listed —
Sool Softener Laxative 50 mg/1; 8.6 mg 49035-0270-30 EQUATE 30 tablets — — FDA listed —
Laxative and Stool Softener 50 mg/1; 8.6 mg 49035-0360-30 EQUATE 30 tablets — — FDA listed —
Senna Time S 50 mg/1; 8.6 min 49483-0081-00 TIME 100000 tablets — — FDA listed —
Sennosides And Docusate Sodium 8.6 mg/1; 50 mg 49483-0097-00 TIME 100000 tablets — — FDA listed —
Laxacin 50 mg/1; 8.6 mg 50488-0901-01 Alexso, 100 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 50804-0304-10 GOOD 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 50804-0855-10 Good 100 tablets — — Discontinued —
Senna S 50 mg/1; 8.6 mg 53329-0989-62 Medline 60 tablets — — FDA listed —
Drug Mart Vegetable Laxative plus Stool Softener 50 mg/1; 8.6 mg 53943-0153-01 Discount 100 tablets — — FDA listed —
Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1; 8.6 mg 53943-0154-01 Discount 100 tablets — — FDA listed —
Senna S 50 mg/1; 8.6 mg 54257-0089-02 Magno-Humphries, 100 tablets — — FDA listed —
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 55154-0195-00 Cardinal 10 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 55154-2578-00 Cardinal 10 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 55319-0565-10 Family 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0829-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0855-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0978-10 Dolgencorp, 100 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 57896-0304-01 Geri-Care 100 tablets — — FDA listed —
Senna Plus 8.6 mg/1; 50 mg 57896-0458-10 Geri-Care 1000 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 57896-0555-01 Geri-Care 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0855-10 P 100 tablets — — FDA listed —
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0878-10 P 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 62011-0417-01 Strategic 100 tablets — — Discontinued —
Docusate Sodium and Sennosides 50 mg/1; 8.6 mg 62993-0002-01 Morepen 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 63561-0187-01 Granulation 100 tablets — — FDA listed —
Stool Softener Stimulant laxative 50 mg/1; 8.6 mg 63868-0875-01 QUALITY 100 tablets — — FDA listed —
Stool Softener plus Laxative 50 mg/1; 8.6 mg 63868-0878-60 QUALITY 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0884-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0946-01 QUALITY 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0855-10 Best 100 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0878-10 Best 100 tablets — — FDA listed —
Stool Softener with laxative 50 mg/1; 8.6 mg 67091-0328-60 WinCo 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 67091-0373-60 WinCo 60 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 68788-7674-01 Preferred 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 68788-8780-01 Preferred 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 69517-0131-02 HealthLife 2 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 69618-0065-01 Reliable-1 100 tablets — — FDA listed —
Colon Detox 50 mg/1; 8.6 mg 69729-0151-60 OPMX 60 tablets — — FDA listed —
Laxative Stool Softener 50 mg/1; 8.6 mg 69842-0776-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0881-10 CVS 100 tablets — — FDA listed —
Senna Plus 50 mg/1; 8.6 mg 69842-0883-18 CVS 180 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0887-10 CVS 100 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71205-0282-30 Proficient 30 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 71205-0970-00 Proficient 100 tablets — — FDA listed —
Senna-Plus 8.6 mg/1; 50 mg 71335-1674-01 Bryant 30 tablets — — FDA listed —
Stool Softener with Laxative 8.6 mg/1; 50 mg 71335-2522-01 Bryant 30 tablets — — FDA listed —
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 71335-2693-01 Bryant 30 tablets — — FDA listed —
Docuzen 8.6 mg/1; 50 mg 71574-0700-60 Village 60 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 72090-0030-20 Pioneer 200 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0855-10 Care 100 tablets — — FDA listed —
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0878-10 Care 100 tablets — — FDA listed —
Senna S Orange 50 mg/1; 8.6 mg 72476-0883-60 Care 60 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 73057-0378-07 Ulai 60 tablets — — FDA listed —
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 76420-0918-01 Asclemed 100 tablets — — FDA listed —
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 79481-0304-01 Meijer, 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 79481-0555-06 Meijer, 60 tablets — — FDA listed —
Stool Softener Laxative 50 mg/1; 8.6 mg 79903-0009-12 WALMART 120 tablets — — FDA listed —
Senna-Plus 50 mg/1; 8.6 mg 80136-0555-01 Heartland 100 tablets — — Discontinued —
Laxacin 50 mg/1; 8.6 mg 80425-0345-01 Advanced 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 80513-0105-25 Advanced 250 tablets — — FDA listed —
Senna With Docusate Sodium 8.6 mg/1; 50 mg 83586-0001-00 HHH 50000 tablets — — FDA listed —
Senna-S 50 mg/1; 8.6 mg 84324-0013-01 NUVICARE 100 tablets — — FDA listed —
Senna-S 8.6 mg/1; 50 mg 85111-0455-10 RMT 1000 tablets — — FDA listed —
Healix Senna-S 8.6 mg/1; 50 mg 87275-2451-01 Brainstorm 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2024
On the market since
May 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00904-7440-61, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
4K
Units reimbursed last 4 qtrs
141.6K
Gross reimbursed last 4 qtrs
$23.4K
Avg / prescription
$5.85
Avg / unit
$0.1651
Latest quarter Q4 2025
1.1KRx
Medicaid pays / ea
$0.1651
gross reimbursed
vs
NADAC / ea
$0.0303
acquisition cost
=
Spread
+$0.1348
+445% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
22% FFS 78% MCO
Fee-for-service · 873 Rx Managed care · 3,127 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: 242 units · 21.4 per 100k residents MT North Dakota: no data reported ND Minnesota: 2,431 units · 42.4 per 100k residents MN Wisconsin: no data reported WI Michigan: 2,687 units · 26.8 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 1,438 units · 103 per 100k residents NH Oregon: 2,579 units · 60.9 per 100k residents OR Nevada: 3,715 units · 116 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 208 units · 6.5 per 100k residents IA Illinois: 2,675 units · 21.3 per 100k residents IL Indiana: 2,034 units · 29.6 per 100k residents IN Ohio: 8,681 units · 73.7 per 100k residents OH Pennsylvania: 52,704 units · 407 per 100k residents PA New Jersey: 10,407 units · 112 per 100k residents NJ Massachusetts: no data reported MA California: 36,279 units · 93.1 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 434 units · 21.9 per 100k residents NE Missouri: 1,976 units · 31.9 per 100k residents MO Kentucky: 4,844 units · 107 per 100k residents KY West Virginia: no data reported WV Virginia: 2,922 units · 33.5 per 100k residents VA Maryland: 1,158 units · 18.7 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 3,777 units · 50.8 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 440 units · 4.0 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.0407
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Pennsylvania 407 /100k
2 Nevada 116 /100k
3 New Jersey 112 /100k
4 Kentucky 107 /100k
5 New Hampshire 103 /100k
6 California 93.1 /100k
7 Ohio 73.7 /100k
8 Oregon 60.9 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Sennosides, Docusate Sodium — the ingredient across all brands.

Top reported reactions

Drug Dependence8
Asthenia5
Constipation5
Abdominal Pain4
Dyspnoea4
Neuropathy Peripheral4
Pain In Extremity4

Age at onset

Neonate2
Adult2

Reporter sex

40 reports
Male · 50%
Female · 50%

Serious outcomes

Hospitalization21
Death5
Disabling1
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 12 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
00904-7440-61 You're viewing this 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-7440-61) / 10 TABLET, FILM COATED in 1 BLISTER PACK 2024-05-01 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 66 words ▾

Directions take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided doses. adults and children 12 years and over take 2-4 tablets daily children 6 to under 12 years of age take 1-2 tablets daily children 2 to under 6 years of age take up to 1 tablet daily children under 2 years ask a doctor

⚠️ Warnings 117 words ▾

laxative products for longer than 1 week unless told to do so by a doctor if you are presently taking mineral oil, unless told to do so by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over two weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. If pregnant or breast-feeding , ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

🆘 Overdosage 15 words ▾

In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 14 words ▾

Drug Facts Active ingredients (in each tablet) Docusate sodium 50 mg Sennosides 8.6 mg

🧪 Inactive Ingredients 40 words ▾

corn starch, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C blue #1 lake, FD&C red #40 lake, FD&C yellow #6 lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, sodium benzoate, sodium lauryl sulfate, stearic acid, talc, titanium dioxide.

🎯 Purpose 5 words ▾

Purposes Stool softener Stimulant laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 00904-7435-35 · Major 00904-7441-20 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.